XML 103 R93.htm IDEA: XBRL DOCUMENT v3.20.2
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Aug. 20, 2020
Jan. 15, 2020
Dec. 22, 2019
Apr. 12, 2019
Mar. 31, 2017
Mar. 09, 2017
Dec. 23, 2019
Sep. 30, 2019
Jun. 30, 2020
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Feb. 05, 2020
Jun. 30, 2019
Aug. 21, 2017
Number of shares issued (in shares)                 140,624            
Short-term loans                   $ 570,000          
Common Stock [Member]                              
Principal amount $ 600,000                 $ 3,977,427       $ 400,000  
Number of shares issued (in shares) 413,793                 182,575          
Fair value of common stock                   $ 1.78       $ 1.07  
Multiplex Laser Surface Enhancement [Member]                              
Proceeds from sale of shares       $ 2,676,219                      
AVLP [Member]                              
Number of shares issued (in shares)                   5,000   91,000      
Number of shares acquired                       372,625      
Value of shares acquired                       $ 208,100      
Fair value of common stock                   $ 1.50          
Amount of shares issued                   $ 1,274   $ 53,032      
Unrealized gain                   488,049          
AVLP [Member] | Common Stock [Member]                              
Unrealized gain                   $ 358,765          
Avalanche International Corp. [Member]                              
Number of warrants purchased                   20,306,921          
MTIX Limited [Member]                              
Proceeds from sale of shares                   $ 1,238,856          
MTIX Limited [Member] | Multiplex Laser Surface Enhancement [Member]                              
Purchase order         $ 50,000,000                    
Alzamend Neuro, Inc. [Member]                              
Number of shares acquired                   11,325          
Value of shares acquired                   $ 9,060          
Alzamend Neuro, Inc. [Member] | 8% Convertible Promissory Note [Member]                              
Interest income for discount accretion               $ 1,968     $ 329        
Alzamend Neuro, Inc. [Member] | 8% Convertible Promissory Note [Member] | Warrant [Member]                              
Unrealized gain                   $ 111          
Number of warrants purchased                   16,667          
Exercise price                   $ 3.00          
Warrant tem                   5 years          
Ault & Company [Member]                              
Short-term loans                   $ 422,758          
Ault & Company [Member] | Convertible Promissory Note [Member]                              
Principal amount                         $ 1,000,000    
Interest rate on debt                         8.00%    
Number of shares issued upon debt conversion 413,793                            
Value of shares issued upon debt conversion $ 600,000                            
Ault & Company [Member] | Short-Term Promissory Note [Member]                              
Principal amount                   2,900,000          
Ault & Company [Member] | 12% Short-Term Promissory Note Due on January 2020 [Member] | Milton C. [Member]                              
Principal amount                   $ 235,796          
Philou [Member] | Manager [Member] | Series B Convertible Preferred Stock [Member]                              
Number of shares issued (in shares)                   125,000          
Loan And Security Agreement [Member] | AVLP [Member]                              
Maximum amount of non-revolving credit facility                             $ 10,000,000
Contractual interest receivable                   $ 2,025,475          
Provision for losses                   5,159,910          
Loan And Security Agreement [Member] | AVLP [Member] | Convertible Promissory Note [Member]                              
Principal amount                   $ 10,153,661          
Interest rate on debt                   12.00%          
Securities Purchase Agreement [Member] | Ault & Company [Member]                              
Number of shares issued (in shares)     660,667                        
Amount of shares issued     $ 739,948                        
Market price of common stock (in dollars per share)     $ 1.12                        
Securities Purchase Agreement [Member] | Ault & Company [Member] | Common Stock [Member]                              
Number of shares issued (in shares)   666,945         660,667                
Fair value of common stock             $ 1.12                
Preferred Stock Purchase Agreement [Member] | Philou [Member] | Series B Convertible Preferred Stock [Member]                              
Description of stock purchase agreement term           Philou which presently owns 125,000 shares of the Company’s Series B Preferred Stock. Mr. Ault and Mr. Horne serve as the Chief Executive Officer and Chief Financial Officer, respectively, of Ault & Company.